Sfoglia per Autore
Adjuvant chemotherapy of gastric cancer: which regimen?
2005 DE VITA, Ferdinando; Orditura, Michele; Ciardiello, Fortunato; Catalano, G.
Farmacogenomica e cancro colorettale
2006 Orditura, Michele; Martinelli, Erika; Morgillo, Floriana; Troiani, Teresa; DE VITA, Ferdinando; Ciardiello, Fortunato
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
2006 Ciardiello, Fortunato; Troiani, Teresa; Caputo, F; De Laurentiis, M; Tortora, G; Palmieri, G; DE VITA, Ferdinando; Diadema, Mr; Orditura, Michele; Colantuoni, G; Gridelli, C; Catalano, G; De Placido, S; Bianco, Ar
Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: A phase II study
2006 Orditura, Michele; Martinelli, Erika; Galizia, Gennaro; Carlomagno, C.; Aurilio, G.; Vecchione, L.; Lieto, Eva; DE PLACIDO, S.; Catalano, G.; Ciardiello, Fortunato; DE VITA, Ferdinando
Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy
2006 Ciardiello, Fortunato; Troiani, Teresa; Bianco, R; Orditura, Michele; Morgillo, Floriana; Martinelli, Erika; Morelli, Mp; Cascone, T. AND TORTORA G.
p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate
2006 Galizia, Gennaro; Ferraraccio, Franca; Lieto, Eva; Orditura, Michele; Castellano, P.; Imperatore, V.; LA MANNA, G.; Pinto, M.; Ciardiello, Fortunato; LA MURA, A.; DE VITA, Ferdinando
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors. A phase I study
2006 Carlomagno, C; Orditura, Michele; Pepe, S; DE VITA, Ferdinando; Romano, C; Ciardiello, Fortunato; Ferrara, C; Martinelli, Erika; Bianco, R; Aurilio, G; Dagostino, D; Tortora, G; Catalano, G; DE PLACIDO, S.
PROGNOSTIC SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR EXPRESSION IN COLON CANCER PATIENTS UNDERGOING CURATIVE SURGERY
2006 Galizia, Gennaro; Lieto, Eva; DE VITA, Ferdinando; Castellano, P; Orditura, Michele; Imperatore, V; La, Mura; LA MANNA, G; Pinto, M; Catalano, G; Ciardiello, Fortunato; PIGNATELLI SPINAZZOLA, C.
Neo-adjuvant and adjuvant chemotherapy of gastric cancer
2007 DE VITA, Ferdinando; Giuliani, F; Galizia, Gennaro; Belli, C; Aurilio, G; Santabarbara, G; Ciardiello, Fortunato; Catalano, G; Orditura, Michele
Effect of cetuximab in recurrent and refractory squamous cell carcinoma of the head and neck (SCCHN): a case report
2007 Schettino, C; Bareschino, Ma; Monaco, K; Orditura, Michele; DE VITA, Ferdinando; Ciardiello, Fortunato
Chemoradiotherapy as adjuvant treatment of gastric cancer
2007 Orditura, Michele; Martinelli, Erika; Galizia, Gennaro; Vitiello, F; Fasano, M; Muto, P; Ciardiello, Fortunato; DE VITA, Ferdinando
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass
2007 Orditura, Michele; Lieto, Eva; Ferraraccio, Franca; DE CATALDIS, G; Troiani, Teresa; Castellano, P; Catalano, G; Ciardiello, Fortunato; Galizia, Gennaro; DE VITA, Ferdinando
Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery
2007 Galizia, Gennaro; Lieto, Eva; Orditura, Michele; Castellano, P; Mura, Al; Imperatore, V; Pinto, M; Zamboli, A; DE VITA, Ferdinando; Ferraraccio, Franca
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)
2007 DE VITA, Ferdinando; Giuliani, F; Orditura, Michele; Maiello, E; Galizia, Gennaro; DI MARTINO, Natale; Montemurro, F; Carten, G; Manzione, L; Romito, S; Gebbia, V; Ciardiello, Fortunato; Catalano, G; Colucci, G; GRUPPO ONCOLOGICO ITALIA, Meridionale
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer
2007 Galizia, Gennaro; Lieto, Eva; DE VITA, Ferdinando; Orditura, Michele; Castellano, P; Troiani, Teresa; Imperatore, V; Ciardiello, Fortunato
First line chemotherapy versus bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases
2008 Galizia, Gennaro; Lieto, Eva; Orditura, Michele; Castellano, P; Imperatore, V; Pinto, M; Zamboli, A.
Integrated therapy in localized gastric cancer: targeted and tailored approach.
2008 Lieto, Eva; Ferraraccio, Franca; Orditura, Michele; Castellano, P; LA MURA, A; Pinto, M; Zamboli, A; DE VITA, Ferdinando; Galizia, Gennaro
Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
2008 Lieto, Eva; Ferraraccio, Franca; Orditura, Michele; Castellano, P.; LA MURA, A.; Pinto, M.; Zamboli, A.; DE VITA, Ferdinando; Galizia, Gennaro
Serum vascular endothelial growth factor (VEGF)levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer
2008 Iovino, Francesco; Ferraraccio, Franca; Orditura, Michele; Antoniol, G.; Morgillo, Floriana; Cascone, T.; Diadema, M. R.; Aurilio, G.; Santabarbara, G.; Ruggiero, Roberto; Belli, C.; Irlandese, E.; Fasano, M.; Ciardiello, Fortunato; Procaccini, Eugenio; LO SCHIAVO, F.; Catalano, G.; DE VITA, Ferdinando
Complete pathological response of colorectal liver metastases after chemotherapy and bevacizumab treatment: a case report
2008 Vitiello, F; Ricci, V; Martinelli, Erika; Orditura, Michele; DE VITA, Ferdinando; Galizia, Gennaro; Ciardiello, Fortunato
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Adjuvant chemotherapy of gastric cancer: which regimen? | 1-gen-2005 | DE VITA, Ferdinando; Orditura, Michele; Ciardiello, Fortunato; Catalano, G. | |
Farmacogenomica e cancro colorettale | 1-gen-2006 | Orditura, Michele; Martinelli, Erika; Morgillo, Floriana; Troiani, Teresa; DE VITA, Ferdinando; Ciardiello, Fortunato | |
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer | 1-gen-2006 | Ciardiello, Fortunato; Troiani, Teresa; Caputo, F; De Laurentiis, M; Tortora, G; Palmieri, G; DE VITA, Ferdinando; Diadema, Mr; Orditura, Michele; Colantuoni, G; Gridelli, C; Catalano, G; De Placido, S; Bianco, Ar | |
Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: A phase II study | 1-gen-2006 | Orditura, Michele; Martinelli, Erika; Galizia, Gennaro; Carlomagno, C.; Aurilio, G.; Vecchione, L.; Lieto, Eva; DE PLACIDO, S.; Catalano, G.; Ciardiello, Fortunato; DE VITA, Ferdinando | |
Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy | 1-gen-2006 | Ciardiello, Fortunato; Troiani, Teresa; Bianco, R; Orditura, Michele; Morgillo, Floriana; Martinelli, Erika; Morelli, Mp; Cascone, T. AND TORTORA G. | |
p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate | 1-gen-2006 | Galizia, Gennaro; Ferraraccio, Franca; Lieto, Eva; Orditura, Michele; Castellano, P.; Imperatore, V.; LA MANNA, G.; Pinto, M.; Ciardiello, Fortunato; LA MURA, A.; DE VITA, Ferdinando | |
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors. A phase I study | 1-gen-2006 | Carlomagno, C; Orditura, Michele; Pepe, S; DE VITA, Ferdinando; Romano, C; Ciardiello, Fortunato; Ferrara, C; Martinelli, Erika; Bianco, R; Aurilio, G; Dagostino, D; Tortora, G; Catalano, G; DE PLACIDO, S. | |
PROGNOSTIC SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR EXPRESSION IN COLON CANCER PATIENTS UNDERGOING CURATIVE SURGERY | 1-gen-2006 | Galizia, Gennaro; Lieto, Eva; DE VITA, Ferdinando; Castellano, P; Orditura, Michele; Imperatore, V; La, Mura; LA MANNA, G; Pinto, M; Catalano, G; Ciardiello, Fortunato; PIGNATELLI SPINAZZOLA, C. | |
Neo-adjuvant and adjuvant chemotherapy of gastric cancer | 1-gen-2007 | DE VITA, Ferdinando; Giuliani, F; Galizia, Gennaro; Belli, C; Aurilio, G; Santabarbara, G; Ciardiello, Fortunato; Catalano, G; Orditura, Michele | |
Effect of cetuximab in recurrent and refractory squamous cell carcinoma of the head and neck (SCCHN): a case report | 1-gen-2007 | Schettino, C; Bareschino, Ma; Monaco, K; Orditura, Michele; DE VITA, Ferdinando; Ciardiello, Fortunato | |
Chemoradiotherapy as adjuvant treatment of gastric cancer | 1-gen-2007 | Orditura, Michele; Martinelli, Erika; Galizia, Gennaro; Vitiello, F; Fasano, M; Muto, P; Ciardiello, Fortunato; DE VITA, Ferdinando | |
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass | 1-gen-2007 | Orditura, Michele; Lieto, Eva; Ferraraccio, Franca; DE CATALDIS, G; Troiani, Teresa; Castellano, P; Catalano, G; Ciardiello, Fortunato; Galizia, Gennaro; DE VITA, Ferdinando | |
Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery | 1-gen-2007 | Galizia, Gennaro; Lieto, Eva; Orditura, Michele; Castellano, P; Mura, Al; Imperatore, V; Pinto, M; Zamboli, A; DE VITA, Ferdinando; Ferraraccio, Franca | |
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) | 1-gen-2007 | DE VITA, Ferdinando; Giuliani, F; Orditura, Michele; Maiello, E; Galizia, Gennaro; DI MARTINO, Natale; Montemurro, F; Carten, G; Manzione, L; Romito, S; Gebbia, V; Ciardiello, Fortunato; Catalano, G; Colucci, G; GRUPPO ONCOLOGICO ITALIA, Meridionale | |
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer | 1-gen-2007 | Galizia, Gennaro; Lieto, Eva; DE VITA, Ferdinando; Orditura, Michele; Castellano, P; Troiani, Teresa; Imperatore, V; Ciardiello, Fortunato | |
First line chemotherapy versus bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases | 1-gen-2008 | Galizia, Gennaro; Lieto, Eva; Orditura, Michele; Castellano, P; Imperatore, V; Pinto, M; Zamboli, A. | |
Integrated therapy in localized gastric cancer: targeted and tailored approach. | 1-gen-2008 | Lieto, Eva; Ferraraccio, Franca; Orditura, Michele; Castellano, P; LA MURA, A; Pinto, M; Zamboli, A; DE VITA, Ferdinando; Galizia, Gennaro | |
Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients. | 1-gen-2008 | Lieto, Eva; Ferraraccio, Franca; Orditura, Michele; Castellano, P.; LA MURA, A.; Pinto, M.; Zamboli, A.; DE VITA, Ferdinando; Galizia, Gennaro | |
Serum vascular endothelial growth factor (VEGF)levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer | 1-gen-2008 | Iovino, Francesco; Ferraraccio, Franca; Orditura, Michele; Antoniol, G.; Morgillo, Floriana; Cascone, T.; Diadema, M. R.; Aurilio, G.; Santabarbara, G.; Ruggiero, Roberto; Belli, C.; Irlandese, E.; Fasano, M.; Ciardiello, Fortunato; Procaccini, Eugenio; LO SCHIAVO, F.; Catalano, G.; DE VITA, Ferdinando | |
Complete pathological response of colorectal liver metastases after chemotherapy and bevacizumab treatment: a case report | 1-gen-2008 | Vitiello, F; Ricci, V; Martinelli, Erika; Orditura, Michele; DE VITA, Ferdinando; Galizia, Gennaro; Ciardiello, Fortunato |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile